BI Asset Management Fondsmaeglerselskab’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-661
| Closed | -$161K | – | 765 |
|
|
2025
Q1 | $161K | Sell |
661
-980
| -60% | -$239K | ﹤0.01% | 642 |
|
|
2024
Q4 | $539K | Buy |
+1,641
| New | +$539K | 0.01% | 624 |
|
|
2024
Q2 | – | Sell |
-1,425
| Closed | -$493K | – | 649 |
|
|
2024
Q1 | $493K | Buy |
1,425
+646
| +83% | +$223K | 0.01% | 532 |
|
|
2023
Q4 | $252K | Buy |
779
+323
| +71% | +$104K | 0.01% | 635 |
|
|
2023
Q3 | $163K | Hold |
456
| – | – | ﹤0.01% | 637 |
|
|
2023
Q2 | $173K | Buy |
456
+134
| +42% | +$50.8K | ﹤0.01% | 627 |
|
|
2023
Q1 | $154K | Buy |
322
+33
| +11% | +$15.8K | ﹤0.01% | 630 |
|
|
2022
Q4 | $122K | Buy |
289
+77
| +36% | +$32.5K | ﹤0.01% | 591 |
|
|
2022
Q3 | $88K | Sell |
212
-135
| -39% | -$56K | ﹤0.01% | 430 |
|
|
2022
Q2 | $172K | Buy |
+347
| New | +$172K | 0.01% | 423 |
|